Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

J Danesh1, P Whincup, M Walker

  • 1Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE.

BMJ (Clinical Research Ed.)
|July 21, 2000
PubMed

Insights

Elevated levels of C-reactive protein and serum amyloid A protein, markers of inflammation, are linked to an increased risk of coronary heart disease. These inflammatory processes may contribute to heart disease independently of chronic infections.

Area of Science:

  • Cardiovascular epidemiology
  • Inflammation research
  • Biomarker analysis

Background:

  • Systemic inflammation is increasingly recognized as a contributor to cardiovascular disease.
  • Identifying specific inflammatory markers associated with coronary heart disease (CHD) risk is crucial for prevention strategies.

Purpose of the Study:

  • To investigate the association between baseline levels of four circulating inflammatory markers and the future risk of coronary heart disease.
  • To explore potential triggers of systemic inflammation and their relationship with other inflammatory markers.

Main Methods:

  • A nested case-control study was conducted within a prospective, population-based cohort of British men aged 40-59.
  • Plasma concentrations of C-reactive protein, serum amyloid A protein, serum albumin, and leucocyte count were measured.
  • Coronary heart disease events (fatal and non-fatal myocardial infarction) were ascertained through medical records and death certificates.

Main Results:

  • Men in the highest third of C-reactive protein levels had more than double the odds of developing coronary heart disease (OR 2.13).
  • Serum amyloid A protein was also significantly associated with increased CHD risk (OR 1.65).
  • Leukocyte count showed a non-significant trend towards increased risk, while serum albumin was associated with reduced risk.

Conclusions:

  • These findings suggest that specific inflammatory processes, independent of the chronic infections studied, play a role in the development of coronary heart disease.
  • C-reactive protein and serum amyloid A protein emerge as significant predictors of future cardiovascular events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...